TDC
EIDX

Thompson Davis & Co’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Thompson Davis & Co’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		$5K Sell
475
-525
-53% -$5.53K 0.01% 588
2018
Q2 		$20K Buy
+1,000
New +$20K 0.05% 315